Factors associated with the clinical outcome of patients with relapsed/refractory CD19(+) acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy
接受 ARI-0001 CART19 细胞疗法治疗的复发/难治性 CD19(+) 急性淋巴细胞白血病患者的临床结局相关因素
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2021-003644
Ortiz-Maldonado, Valentín; Rives, Susana; Español-Rego, Marta; Alonso-Saladrigues, Anna; Montoro, Mercedes; Magnano, Laura; Giné, Eva; Pascal, Mariona; Díaz-Beyá, Marina; Castella, Maria; Català, Albert; Faura, Anna; Rodríguez-Lobato, Luis Gerardo; Oliver-Caldes, Aina; Martínez-Roca, Alexandra; Rovira, Montserrat; González-Navarro, E Azucena; Ortega, Juan Ramón; Cid, Joan; Lozano, Miquel; Garcia-Rey, Enric; Fernández, Sara; Castro, Pedro; Jordan, Iolanda; Villamor, Neus; Aymerich, Marta; Torrebadell, Montserrat; Deyà, Àngela; Fernández de Larrea, Carlos; Benitez-Ribas, Daniel; Trias, Esteve; Varea, Sara; Calvo, Gonzalo; Esteve, Jordi; Urbano-Ispizua, Alvaro; Juan, Manel; Delgado, Julio